DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Summary

The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is soliciting proposals for a Clinical Translational Research Award focused on Tuberous Sclerosis Complex (TSC) under the Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). The award targets clinical or translational research advancing understanding, diagnosis, or treatment of TSC. Full scope details, eligibility criteria, and funding levels are not provided in the synopsis; the full funding opportunity announcement (FOA) is expected to contain those details.

What they want

How they evaluate

Risks & flags

• Extremely limited information in synopsis — no funding level, eligibility requirements, or scope of work disclosed; full evaluation criteria unavailable at this stage
• Short synopsis with no attachments makes it difficult to assess competitiveness or potential incumbency